Source: ST

Hours after two Progress Singapore Party (PSP) politicians had publically speculated on the mainstream media’s silence regarding Singapore Democratic Party (SDP) chairman Paul Tambyah’s new role as the President-Elect of the International Society of Infectious Diseases (ISID), The Straits Times had finally published a report regarding Dr Tambyah’s achievement.

The report was published on the ST website on Wednesday evening (17 June).

The mainstream media platform quoted Dr Tambyah as saying regarding his new position at ISID: “This is a critical time for infectious diseases globally. The Covid-19 pandemic has brought home the fact that viruses do not respect international boundaries. No one is safe anywhere until everyone is safe everywhere.”

“Singapore academics, clinicians and public health professionals have much to contribute to societies such as ISID to help make the world a healthier place for everyone,” Dr Tambyah added.

ST noted in its report that Dr Tambyah is the chairman of SDP.

An article on Dr Tambyah’s new role also appeared in ST’s print edition today (18 June). However, it was discreetly placed at the bottom of Page B4 under the “Home” section.

Source: ST

SDP in a Facebook post on Monday (15 June) disclosed that Dr Tambyah has been elected as the Boston-based Society’s current President-Elect.

The role of the President-Elect entails supporting the president and assuming the role of the president when required. Being on track for the role of the President, Dr Tambyah will be learning the means of operations for the society, and may also chair some committees at the discretion of the president, according to ISID.

“Who say opposition has no talent? We have far more talent outside the government than inside it. More importantly there is diversity as well,” said PSP assistant secretary-general Leong Mun Wai in a Facebook post on Tuesday (16 June).

Mr Leong questioned if Dr Tambyah’s status as an opposition politician in Singapore is behind the absence of mainstream media reports on the infectious disease expert’s new feat.

“I thought especially with Covid 19, all the talents we have on infectious diseases should be accorded special attention,” he added.

PSP member Brad Bowyer in another Facebook post on Tuesday said that Singapore needs “need more recognition of our national talents on the International stage”.

He added that such talents should be roped into efforts to tackle “a national emergency” when it is proved that their “domain knowledge” fits the bill.

Members of the public have also previously questioned why Dr Tambyah was not included in Singapore’s taskforce for COVID-19, given his internationally-acclaimed expertise as an infectious disease specialist.

Dr Paul Tambyah “well-known to all in the field of infectious diseases”, has “formidable experience across the spectrum of infection”: ISID immediate past president

Dr Tambyah is set to commence his term as President of ISID in 2022.

Currently, Imperial College London infectious disease professor Alison Holmes serves as president of ISID.

Dr Holmes is also a Fellow of the United Kingdom’s Academy of Medical Sciences and a National Institute of Health Research (NIHR) Senior Investigator.

Marc Mendelson, the immediate past president of ISID, said that Dr Tambyah is “is well-known to all in the field of infectious diseases, and brings a wealth of experience from his time with multiple international societies and august bodies, as well as formidable experience across the spectrum of infection, including outbreaks, tropical medicine, and clinical applied research”.

“He is a go-to speaker on so many topics and currently serves as Chair of the ISID Publications Committee, playing a vital role in the success of our journal IJID [International Journal of Infectious Diseases],” added Dr Mendelson, who is a professor of Infectious Diseases and spearheads the Division of Infectious Diseases & HIV Medicine at Groote Schuur Hospital at the University of Cape Town in South Africa.

Dr Tambyah also currently serves as a professor of Medicine at the National University of Singapore and Senior Consultant Infectious Diseases Physician at the National University Hospital.

He is also the immediate past president of the Singapore Society of Infectious Diseases and Secretary-General of the Asia Pacific Society of Clinical Microbiology and Infection.

Among ISID’s notable feats include launching the Program for Monitoring Emerging Diseases (PROMED) in 1994.

PROMED is an online service designed to identify unusual health events related to emerging and re-emerging infectious diseases and toxins affecting humans, animals and plants, according to ISID.

The service is used daily by international public health leaders, government officials at all levels, physicians, veterinarians and other healthcare workers, researchers, private companies, journalists and the general public.

 

Subscribe
Notify of
8 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
You May Also Like

【选举】年龄介于30至50岁 人民行动党介绍八准候选人

人民行动党今天宣布增加了八名准候选人,年龄介于30岁至50岁。 行动党第一助理秘书长王瑞杰今天通过视讯记者会,宣布该党将会参选所有的93个议席,之后就介绍了四名准候选人。 他们分别为,人民协会前任总执行理事长的陈国明(50岁)、餐饮与音乐集团Timbre联合创办人谢秉辉(36岁)、曾担任《亚洲新闻台》记者的娜蒂雅律师(Nadia Ahmad Samdin,30岁),以及吉宝岸外与海事总经理的林绍权(42岁)。 较后,党副主席马善高也在视讯会议上介绍了另外四名准候选人。 他们分别为,护联中心旗下关爱乐龄办事处(Silver Generation Office)前总署长叶汉荣(43岁)、律师事务所董事苏慧敏(33岁)、大华银行高级副总裁黄文鸿(43岁),以及全国职总行政研究署处长阀贺米(Fahmi Aliman,48岁)。阀贺米也是原回教理事会(MUIS)的副理事长。

Amateurs – and loving it

By Joshua Chiang am·a·teur (m-tûr, -tr, -chr, -chr, -tyr) A person who engages…

【选举】李显扬和陈清木 一同攻打丹戎巴葛?

新加坡前进党在本周在政坛抛下震撼弹,宣布建国总理李光耀次子李显扬已入党。更巧妙的是,该党秘书长陈清木医生,选择在中峇鲁巴刹这个地方,移交党员证给后者。 中峇鲁就位在丹戎巴葛选区,过去就是由时任内阁资政的李光耀领军,目前由贸工部长陈振声等人镇守。 而在明日(27日)晚上8时,前进党将直播主题为“回家:丹戎巴葛的故事”线上演说。该党形容,丹戎巴葛如同新加坡的缩影,是新加坡发展的中心点、也是该党许多成员,包括陈清木成长的地方,欢迎民众一同来聆听和分享人在丹戎巴葛的往事回忆。 对于李显扬会否在本届选举上阵,尽管早前陈清木卖关子不愿透露,惟坊间已在揣测,他俩会否一同攻打丹戎巴葛集选区?再者该选区对李显扬也具有显著意义,在父亲过去的选区上阵,能否争取更多选民的响应? 迄今,行动党似乎仍未公布该党在丹戎巴葛的候选人,似乎仍在观望对手布局。  

今年第二季运营盈利1390万元 新捷运称轻轨亏损 吁公交理事会调整车资

根据新捷运(SBS Transit)2017年度报告,显示该公司从2013年以来的营收和股东应占盈利(profit attributable to shareholders),都呈现增长之势。 该公司去年的运营盈利达到5千930万新元,比2015年增长两倍。至于股东应占盈利,则从2015年的1千670万新元,三倍跃进至去年的4千710万新元。 根据新捷运发表的2018年第二季度表现,在公共交通服务方面的营收达到3亿3010万元,比2017年同季度还要高20.3巴仙。 在该报告中称,更高的车资,以及自2018年3月开跑的实里达配套和去年10月开跑的3号DTL捷运线,增加了该季度营收。 客流量增,惟轻轨面临亏损 在第二季度,DTL线路每日平均客流量增长了80.6巴仙,达到43万7千人次;东北线与2017年第二季度相比,每日平均客流量增长2.3巴仙,达到57万9千人次;轻轨平均乘客量增8.1巴仙至12万9千人次。 2018年第二季度的运营盈利(operating profit)达到1千390万元,比去年同季增加了660万元,原因是较高的营收抵消了其他增长的员工成本、燃油和电力、维修保养等运营成本。…